Cargando…
Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study
Background and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH). Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to A...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770748/ https://www.ncbi.nlm.nih.gov/pubmed/35071222 http://dx.doi.org/10.3389/fbioe.2021.826926 |
_version_ | 1784635434292215808 |
---|---|
author | Yu, Xuan Chang, Jiandong Zhang, Dezhi Lu, Qiang Wu, Songsong Li, Kai |
author_facet | Yu, Xuan Chang, Jiandong Zhang, Dezhi Lu, Qiang Wu, Songsong Li, Kai |
author_sort | Yu, Xuan |
collection | PubMed |
description | Background and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH). Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to August 2021 at five medical centers in China was conducted. Results: A total of 53 patients were included (26 males and 27 females). The mean age was 35.1 ± 10.8 years. Sixty-five lesions (46 solitary cases and 7 cases with multiple lesions) were included, 70.8% (46/65) of which were located in the right liver lobe. The mean tumor length was 2.9 ± 1.5 cm. All patients successfully completed the ablation treatment. Immediate postoperative imaging showed that the primary technical success rate was 94.3% (50/53). Two patients underwent ablation 3 and 6 months after the primary ablation, and the secondary technical success rate was 100% (2/2). The incidence of complications was 3.8% (2/53). Imaging follow-up was conducted regularly after ablation, and no residual lesion enlargement or tumor recurrence was observed during the follow-up period. The technique efficacy rate was 98.1% (52/53). Conclusion: US-guided percutaneous thermal ablation is a safe and effective treatment for FNH of the liver. |
format | Online Article Text |
id | pubmed-8770748 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-87707482022-01-21 Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study Yu, Xuan Chang, Jiandong Zhang, Dezhi Lu, Qiang Wu, Songsong Li, Kai Front Bioeng Biotechnol Bioengineering and Biotechnology Background and Aim: To evaluate the clinical effect of ultrasound (US)-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia (FNH). Methods: A retrospective analysis of the clinical data of patients undergoing US-guided percutaneous thermal ablation of FNH from November 2008 to August 2021 at five medical centers in China was conducted. Results: A total of 53 patients were included (26 males and 27 females). The mean age was 35.1 ± 10.8 years. Sixty-five lesions (46 solitary cases and 7 cases with multiple lesions) were included, 70.8% (46/65) of which were located in the right liver lobe. The mean tumor length was 2.9 ± 1.5 cm. All patients successfully completed the ablation treatment. Immediate postoperative imaging showed that the primary technical success rate was 94.3% (50/53). Two patients underwent ablation 3 and 6 months after the primary ablation, and the secondary technical success rate was 100% (2/2). The incidence of complications was 3.8% (2/53). Imaging follow-up was conducted regularly after ablation, and no residual lesion enlargement or tumor recurrence was observed during the follow-up period. The technique efficacy rate was 98.1% (52/53). Conclusion: US-guided percutaneous thermal ablation is a safe and effective treatment for FNH of the liver. Frontiers Media S.A. 2022-01-06 /pmc/articles/PMC8770748/ /pubmed/35071222 http://dx.doi.org/10.3389/fbioe.2021.826926 Text en Copyright © 2022 Yu, Chang, Zhang, Lu, Wu and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Bioengineering and Biotechnology Yu, Xuan Chang, Jiandong Zhang, Dezhi Lu, Qiang Wu, Songsong Li, Kai Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_full | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_fullStr | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_full_unstemmed | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_short | Ultrasound-Guided Percutaneous Thermal Ablation of Hepatic Focal Nodular Hyperplasia——A Multicenter Retrospective Study |
title_sort | ultrasound-guided percutaneous thermal ablation of hepatic focal nodular hyperplasia——a multicenter retrospective study |
topic | Bioengineering and Biotechnology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770748/ https://www.ncbi.nlm.nih.gov/pubmed/35071222 http://dx.doi.org/10.3389/fbioe.2021.826926 |
work_keys_str_mv | AT yuxuan ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT changjiandong ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT zhangdezhi ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT luqiang ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT wusongsong ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy AT likai ultrasoundguidedpercutaneousthermalablationofhepaticfocalnodularhyperplasiaamulticenterretrospectivestudy |